CMS released the fiscal year (FY) 2020 IPPS final rule on August 2, increasing inpatient operating payment rates by 3.1%, significantly altering rural health payments, expediting opportunities to pay for new technologies, and updating CCs, MCCs, and MS-DRGs. These policy updates affect approximately 3,300 acute care hospitals and apply to discharges occurring on and after October 1.
The American Hospital Association (AHA) released Coding Clinic, Second Quarter 2019, just in time for summer vacation. If Coding Clinic didn’t make your summer must-read list, then be sure to review this article, which summarizes coding updates discussed in the quarterly newsletter and their impact on severity and DRG assignment
We have come a long way in our understanding of post-traumatic stress disorder (PTSD) but still have a lot to learn about the condition’s prevalence and impact.
Sepsis is a potentially fatal condition that affects nearly 1.7 million adults in America each year, according to the Centers for Disease Control and Prevention (CDC). Nearly 270,000 Americans die each year from sepsis-related complications.
When you work in the CDI program of a medical facility, you are continually thinking of ways to elicit improved documentation from the medical staff. You also spend a fair amount of time lamenting why some physicians or service lines seem to ignore all educational efforts regarding the importance of explicit and accurate documentation. “If it is important to us,” you might say, “why is it not to them?”
Keeping up with coding changes in the circulatory system chapter in the ICD-10-CM manual is an ongoing process. Almost every fiscal year coders are met with new codes for myocardial infarctions (MI), changes to congestive heart failure codes, and updates to the guidelines for reporting cerebrovascular diseases.
This summary, organized by major diagnostic category (MDC), highlights some of the changes to the IPPS proposed rule affecting MS-DRG and ICD-10-CM/PCS code assignment.
Acute kidney injury (AKI) and acute tubular necrosis (ATN) remain targets for both coding and clinical validation. Over the years, we’ve gleaned valuable insights from appealing hundreds of coding and clinical validation denials for AKI and ATN.
